{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:55:45Z","timestamp":1790805345814,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T00:00:00Z","timestamp":1773792000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100015303","name":"Otsuka Pharmaceutical Development and Commercialization","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015303","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","intpsychogeriatrics.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Psychogeriatrics"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.inpsyc.2026.100209","type":"journal-article","created":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T03:56:07Z","timestamp":1776484567000},"page":"100209","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Treatment patterns of agitation associated with Alzheimer\u2019s dementia (AAD) patients in Canada"],"prefix":"10.1016","volume":"38","author":[{"given":"Veronique","family":"Littmann-Crites","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Marilise","family":"Marrache","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9010-9039","authenticated-orcid":false,"given":"Ceryl","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9988-216X","authenticated-orcid":false,"given":"Natalie","family":"Nightingale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Calum S.","family":"Neish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francois","family":"Therrien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5529-3731","authenticated-orcid":false,"given":"Zahinoor","family":"Ismail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.inpsyc.2026.100209_bib1","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1017\/S1041610222001041","article-title":"Agitation in cognitive disorders: progress in the International Psychogeriatric Association consensus clinical and research definition","volume":"36","author":"Sano","year":"2024","journal-title":"Int Psychogeriatr"},{"key":"10.1016\/j.inpsyc.2026.100209_bib2","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1002\/alz.12335","article-title":"Agitation in Alzheimer\u2019s disease: Novel outcome measures reflecting the International Psychogeriatric Association (IPA) agitation criteria","volume":"17","author":"De Mauleon","year":"2021","journal-title":"Alzheimer\u2019S & Dement"},{"key":"10.1016\/j.inpsyc.2026.100209_bib3","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1017\/S1041610218001898","article-title":"Agitation in patients with dementia: a systematic review of epidemiology and association with severity and course","volume":"31","author":"Anatchkova","year":"2019","journal-title":"Int Psychogeriatr"},{"key":"10.1016\/j.inpsyc.2026.100209_bib4","first-page":"1","article-title":"A real-world assessment of healthcare costs associated with agitation in Alzheimer\u2019s dementia","author":"Grossberg","year":"2023","journal-title":"J Med Econ"},{"key":"10.1016\/j.inpsyc.2026.100209_bib5","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/ana.72","article-title":"Orbitofrontal and anterior cingulate cortex neurofibrillary tangle burden is associated with agitation in Alzheimer disease","volume":"49","author":"Tekin","year":"2001","journal-title":"Ann Neurol"},{"key":"10.1016\/j.inpsyc.2026.100209_bib6","doi-asserted-by":"crossref","first-page":"269","DOI":"10.2217\/nmt.12.19","article-title":"Impact of neuropsychiatric symptoms on caregiver burden in patients with Alzheimer\u2019s disease","volume":"2","author":"Fischer","year":"2012","journal-title":"Neurodegener Dis Manag"},{"key":"10.1016\/j.inpsyc.2026.100209_bib7","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1186\/s12877-024-04919-0","article-title":"Barriers and facilitators to care for agitation and\/or aggression among persons living with dementia in long-term care","volume":"24","author":"Wong","year":"2024","journal-title":"BMC Geriatr"},{"key":"10.1016\/j.inpsyc.2026.100209_bib8","first-page":"440","article-title":"Neuropsychiatric signs and symptoms of Alzheimer\u2019s disease: new treatment paradigms","volume":"3","author":"Lanct\u00f4t","year":"2017","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.inpsyc.2026.100209_bib9","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1177\/14713012251340463","article-title":"Agitation in individuals with Alzheimer\u2019s disease: an assessment of behaviors using the cohen-mansfield agitation inventory in community-dwellers and impact on caregiver experience","volume":"25","author":"Grossberg","year":"2026","journal-title":"Dementia"},{"key":"10.1016\/j.inpsyc.2026.100209_bib10","article-title":"Blood biomarkers for Alzheimer\u2019s disease are correlated with measures of agitation and cognition in a randomized trial assessing the effects of escitalopram on agitation","volume":"12","author":"Barnwal","year":"2026","journal-title":"Alzheimer\u2019S Dement Transl Res Clin Interv"},{"key":"10.1016\/j.inpsyc.2026.100209_bib11","doi-asserted-by":"crossref","first-page":"91","DOI":"10.5770\/cgj.28.820","article-title":"The Canadian coalition for seniors\u2019 Mental Health Canadian Clinical practice guidelines for assessing and managing behavioural and psychological symptoms of dementia (BPSD)","volume":"28","author":"Hatch","year":"2025","journal-title":"Can Geriatr J"},{"key":"10.1016\/j.inpsyc.2026.100209_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.644317","article-title":"Agitation and dementia: prevention and treatment strategies in acute and chronic conditions","volume":"12","author":"Carrarini","year":"2021","journal-title":"Front Neurol"},{"key":"10.1016\/j.inpsyc.2026.100209_bib13","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1017\/S104161022200103X","article-title":"Reduction and prevention of agitation in persons with neurocognitive disorders: an international psychogeriatric association consensus algorithm","volume":"36","author":"Cummings","year":"2024","journal-title":"Int Psychogeriatr"},{"key":"10.1016\/j.inpsyc.2026.100209_bib14","unstructured":"Ismail, Z. & Goodarzi, Z. Neuropsychiatric Aspects of Alzheimer \u2019 s Disease Clinically significant neuropsychiatric symptoms need evidence-based treatment. in, 2019."},{"key":"10.1016\/j.inpsyc.2026.100209_bib15","doi-asserted-by":"crossref","unstructured":"Watt, J.A., Ismail, Z., Lane, N., Seitz, D. & Goodarzi, Z. Management of Behavioral and Psychological Symptoms of Dementia: Nonpharmacologic and Pharmacologic Interventions. https:\/\/doi.org\/10.1146\/annurev-clinpsy-061724-085912, 2026, doi:10.1146\/annurev-clinpsy-061724-085912.","DOI":"10.1146\/annurev-clinpsy-061724-085912"},{"key":"10.1016\/j.inpsyc.2026.100209_bib16","doi-asserted-by":"crossref","DOI":"10.1136\/bmjment-2024-301019","article-title":"Efficacy, acceptability and tolerability of second-generation antipsychotics for behavioural and psychological symptoms of dementia: a systematic review and network meta-analysis","volume":"27","author":"L\u00fc","year":"2024","journal-title":"BMJ Ment Health"},{"key":"10.1016\/j.inpsyc.2026.100209_bib17","first-page":"50","article-title":"Beyond the black box: what is the role for antipsychotics in dementia?","volume":"7","author":"Meeks","year":"2008","journal-title":"Curr Psychiatr"},{"key":"10.1016\/j.inpsyc.2026.100209_bib18","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1177\/0269881117744996","article-title":"Sequential drug treatment algorithm for agitation and aggression in Alzheimer\u2019s and mixed dementia","volume":"32","author":"Davies","year":"2018","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.inpsyc.2026.100209_bib19","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.jamda.2024.03.007","article-title":"Guideline recommendations on behavioral and psychological symptoms of dementia: a systematic review","volume":"25","author":"Watt","year":"2024","journal-title":"J Am Med Dir Assoc"},{"key":"10.1016\/j.inpsyc.2026.100209_bib20","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1186\/s12877-024-05143-6","article-title":"Detecting agitation and aggression in persons living with dementia: a systematic review of diagnostic accuracy","volume":"24","author":"Wong","year":"2024","journal-title":"BMC Geriatr"},{"key":"10.1016\/j.inpsyc.2026.100209_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2018.00054","article-title":"1st International Experts\u2019 Meeting on Agitation: conclusions regarding the current and ideal management paradigm of agitation","volume":"9","author":"Mart\u00ednez-Raga","year":"2018","journal-title":"Front Psychiatry"},{"key":"10.1016\/j.inpsyc.2026.100209_bib24","unstructured":"Government of New Brunswick, C. NB Drug Plans. \u3008https:\/\/www2.gnb.ca\/content\/gnb\/en\/departments\/health\/DrugPlans\/content\/drugplans.html\u3009 ,2021."},{"key":"10.1016\/j.inpsyc.2026.100209_bib25","unstructured":"Get coverage for prescription drugs | ontario.ca. \u3008http:\/\/www.ontario.ca\/page\/get-coverage-prescription-drugs\u3009."},{"key":"10.1016\/j.inpsyc.2026.100209_bib26","doi-asserted-by":"crossref","first-page":"575","DOI":"10.3233\/ADR-230009","article-title":"Characterizing PRN use of psychotropic medications for acute agitation in Canadian long-term care residents with dementia before and during COVID-19","volume":"7","author":"Wang","year":"2023","journal-title":"J Alzheimers Dis Rep"},{"key":"10.1016\/j.inpsyc.2026.100209_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13670-019-0269-1","article-title":"Pharmacologic management of agitation in patients with dementia","volume":"8","author":"McDermott","year":"2019","journal-title":"Curr Geriatr Rep"},{"key":"10.1016\/j.inpsyc.2026.100209_bib28","first-page":"11","article-title":"Alzheimer\u2019s disease and other dementias in Canada","volume":"27","author":"Wong","year":"2016","journal-title":"Health Rep"},{"key":"10.1016\/j.inpsyc.2026.100209_bib29","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1002\/gps.5604","article-title":"Impact of agitation in long-term care residents with dementia in the United States","volume":"36","author":"Fillit","year":"2021","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.inpsyc.2026.100209_bib30","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004990","article-title":"Trazodone for agitation in dementia","author":"Martinon-Torres","year":"2004","journal-title":"Cochrane Database Syst Rev CD004990"},{"key":"10.1016\/j.inpsyc.2026.100209_bib31","doi-asserted-by":"crossref","first-page":"pyv055","DOI":"10.1093\/ijnp\/pyv055","article-title":"Use of benzodiazepines in Alzheimer\u2019s Disease: A Systematic Review of Literature","volume":"18","author":"Defrancesco","year":"2015","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.inpsyc.2026.100209_bib32","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/BF00634466","article-title":"Low-dose oral lorazepam administration in Alzheimer subjects and age-matched controls","volume":"99","author":"Sunderland","year":"1989","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.inpsyc.2026.100209_bib33","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1590\/S0004-282X2001000600005","article-title":"Efficacy and safety of risperidone oral solution in agitation associated with dementia in the elderly","volume":"59","author":"Laks","year":"2001","journal-title":"Arq Neuropsiquiatr"},{"key":"10.1016\/j.inpsyc.2026.100209_bib34","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/j.jalz.2019.06.4946","article-title":"Escitalopram for agitation in Alzheimer\u2019s disease (S-CitAD): methods and design of an investigator-initiated, randomized, controlled, multicenter clinical trial","volume":"15","author":"Ehrhardt","year":"2019","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.inpsyc.2026.100209_bib35","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.pnpbp.2006.09.001","article-title":"Clinical experience with risperidone in the treatment of behavioral and psychological symptoms of dementia","volume":"31","author":"Onor","year":"2007","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.inpsyc.2026.100209_bib36","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/JCP.0000000000000710","article-title":"Aripiprazole once-monthly in the treatment of acute psychotic episodes in Schizophrenia: post hoc analysis of positive and negative syndrome scale marder factor scores","volume":"37","author":"Ismail","year":"2017","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.inpsyc.2026.100209_bib37","doi-asserted-by":"crossref","first-page":"118","DOI":"10.36469\/jheor.2024.124455","article-title":"Healthcare resource utilization among patients with agitation in Alzheimer dementia","volume":"11","author":"Teigland","year":"2024","journal-title":"J Health Econ Outcomes Res"}],"container-title":["International Psychogeriatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104161022600027X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104161022600027X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T20:55:32Z","timestamp":1790801732000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S104161022600027X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S104161022600027X"],"URL":"https:\/\/doi.org\/10.1016\/j.inpsyc.2026.100209","relation":{},"ISSN":["1041-6102"],"issn-type":[{"value":"1041-6102","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment patterns of agitation associated with Alzheimer\u2019s dementia (AAD) patients in Canada","name":"articletitle","label":"Article Title"},{"value":"International Psychogeriatrics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.inpsyc.2026.100209","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of International Psychogeriatric Association.","name":"copyright","label":"Copyright"}],"article-number":"100209"}}